[Malignant second tumors in patients after therapy of Hodgkin's disease at the Royal Marsden Hospital].
Glanzmann
C
C
D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D007953:Leukemia, Radiation-Induced / Q000209:etiology*; D015999:Multivariate Analysis; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000209:etiology; D012307:Risk Factors; D013997:Time Factors
Maligne Zweittumoren bei PatientInnen nach Therapie eines Morbus Hodgkin am Royal Marsden Hospital.